Cent Eur J Public Health 2025, 33(2):83-87 | DOI: 10.21101/cejph.a8270
Colorectal cancer screening to identify undiagnosed hepatitis C in an Austrian cohort
- 1 Department of Internal Medicine, Saint John of God Hospital, Teaching Hospital of the Paracelsus Medical Private University, Salzburg, Austria
- 2 Department of Internal Medicine, General Hospital Oberndorf, Teaching Hospital of the Paracelsus Medical Private University, Oberndorf, Austria
- 3 Biomedical Sciences, Salzburg University of Applied Sciences, Salzburg, Austria
- 4 Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria
- 5 Clinic I for Internal Medicine, University Hospital Salzburg, Paracelsus Medical Private University, Salzburg, Austria
- 6 Department of Nuclear Medicine, University Hospital Salzburg, Paracelsus Medical Private University, Salzburg, Austria
Objectives: Hepatitis C virus (HCV) infection remains a significant public health concern despite the introduction of direct acting antiviral agents. To reach the World Health Organization (WHO) goal of eliminating viral hepatitis as a public health threat by 2030, adequate screening strategies and early diagnosis are crucial. This study aimed to determine the prevalence of HCV infection in an Austrian cohort and assess the feasibility of incorporating HCV screening into colorectal screening programmes.
Methods: The study enrolled 1,894 asymptomatic individuals during a colorectal screening programme with a mean age of 57 (± 7 years) years. Sera of the participants were screened for HCV-specific antibodies, and blood samples of individuals with detectable HCV-specific antibodies were tested by the polymerase chain reaction (PCR) to confirm a chronic HCV infection. Furthermore, we evaluated the characteristics of these individuals including their anthropometrics, biomarkers, and liver-specific information such as those obtained with a fibroscan.
Results: We found that 14 (0.74%) of the participants had detectable levels of HCV-specific antibodies, with 6 (0.32%) individuals being newly diagnosed with a chronic HCV infection. One of the 6 patients showed signs of liver cirrhosis. The newly diagnosed individuals included 4 cases of HCV genotype 1a and 2 cases of 1b.
Conclusion: Our study highlights the importance of screening for HCV infection in asymptomatic individuals, not only for those at risk of HCV exposure or with elevated liver enzymes. Incorporating HCV screening into colorectal screening programmes could be an effective strategy for increasing the rate of HCV diagnosis, thereby improving public health outcomes. Further investigation is needed regarding cost-effectiveness and strategies to reach individuals who have no access to screening programmes or do not adhere to regular preventive screenings.
Keywords: chronic HCV infection, HCV screening, population-based screening, HCV, HCV genotype
Received: May 2, 2024; Revised: April 14, 2025; Accepted: April 14, 2025; Published: June 30, 2025 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017 Mar;2(3):161-76.
- Solomon SS, Mehta SH, Srikrishnan AK, Solomon S, McFall AM, Laeyendecker O, et al. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study. Lancet Infect Dis. 2015 Jan;15(1):36-45.
Go to original source...
Go to PubMed...
- Jordan AE, Perlman DC, Neurer J, Smith DJ, Des Jarlais DC, Hagan H. Prevalence of hepatitis C virus infection among HIV+ men who have sex with men: a systematic review and meta-analysis. Int J STD AIDS. 2017 Feb;28(2):145-59.
Go to original source...
Go to PubMed...
- Spearman CW, Dusheiko GM, Hellard M, Sonderup M. Hepatitis C. Lancet. 2019 Oct 19;394(10207):1451-66.
Go to original source...
Go to PubMed...
- Herold G. [Internal Medicine 2023]. Berlin: De Gruyter Brill; 2023. German.
- World Health Organization. Global health sector strategy on viral hepatitis 2016-2021: towards ending viral hepatitis [Internet]. Geneva: WHO; 2016 [cited 2025 Apr 14]. Available from: https://apps.who.int/iris/bitstream/handle/10665/246177/who?sequence=1.
- European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C 2016. J Hepatol. 2017 Jan;66(1):153-94.
Go to original source...
Go to PubMed...
- Polaris Observatory HCV Collaborators. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study. Lancet Gastroenterol Hepatol. 2022 May;7(5):396-415.
- Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015 Jan;61(1):77-87.
Go to original source...
Go to PubMed...
- Liu CH, Kao JH. Acute hepatitis C virus infection: clinical update and remaining challenges. Clin Mol Hepatol. 2023 Jul;29(3):623-42.
Go to original source...
Go to PubMed...
- US Preventive Services Task Force; Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, et al. Screening for hepatitis C virus infection in adolescents and adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2020 Mar 10;323(10):970-5.
Go to original source...
Go to PubMed...
- Sears DM, Cohen DC, Ackerman K, Ma JE, Song J. Birth cohort screening for chronic hepatitis during colonoscopy appointments. Am J Gastroenterol. 2013 Jun;108(6):981-9.
Go to original source...
Go to PubMed...
- US Preventive Services Task Force; Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, et al. Screening for colorectal cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021 May 18;325(19):1965-77.
Go to original source...
Go to PubMed...
- Gsur A, Baierl A, Brezina S. Colorectal Cancer Study of Austria (CORSA): a population-based multicenter study. Biology (Basel). 2021 Jul 28;10(8):722. doi: 10.3390/biology10080722.
Go to original source...
Go to PubMed...
- Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al.; APRICOT Clinical Investigators. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006 Jun;43(6):1317-25.
Go to original source...
Go to PubMed...
- Lackner C, Struber G, Liegl B, Leibl S, Ofner P, Bankuti C, et al. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology. 2005 Jun;41(6):1376-82.
Go to original source...
Go to PubMed...
- Wernly S, Semmler G, Schaffler-Schaden D, Flamm M, Aigner E, Datz C, et al. The association between educational status and colorectal neoplasia: results from a screening cohort. Int J Colorectal Dis. 2023 Apr 5;38(1):91. doi: 10.1007/s00384-023-04383-z.
Go to original source...
Go to PubMed...
- Wernly S, Semmler G, Völkerer A, Flamm M, Aigner E, Niederseer D, et al. Helicobacter pylori and cardiovascular risk: only a dead Helicobacter is a good Helicobacter? Helicobacter. 2022 Dec;27(6):e12928. doi: 10.1111/hel.12928.
Go to original source...
Go to PubMed...
- Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC Med. 2011 May 5;9:48. doi: 10.1186/1741-7015-9-48.
Go to original source...
Go to PubMed...
- Semmler G, Meyer EL, Kozbial K, Schwabl P, Hametner-Schreil S, Zanetto A, et al. HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease. J Hepatol. 2022 Apr;76(4):812-21.
Go to original source...
Go to PubMed...
- Labenz C, Arslanow A, Nguyen-Tat M, Nagel M, Wörns MA, Reichert MC, et al. Structured early detection of asymptomatic liver cirrhosis: results of the population-based liver screening program SEAL. J Hepatol. 2022 Sep;77(3):695-701.
Go to original source...
Go to PubMed...
- Strauss R, Fülöp G, Pfeifer C. Hepatitis C in Austria 1993-2000: reporting bias distort HCV epidemiology in Austria. Euro Surveill. 2003 May;8(5):113-8.
Go to original source...
Go to PubMed...
- Maieron A, Metz-Gercek S, Hackl F, Luger C, Ziachehabi A, Strauss R, et al. Chronic hepatitis C in Austria, 1992-2006: genotype distribution and demographic factors. Euro Surveill. 2010 Feb 25;15(8):19492. doi: 10.2807/ese.15.08.19492-en.
Go to original source...
Go to PubMed...
- Ferenci P, Ferenci S, Datz C, Rezman I, Oberaigner W, Strauss R. Morbidity and mortality in paid Austrian plasma donors infected with hepatitis C at plasma donation in the 1970s. J Hepatol. 2007 Jul;47(1):31-6.
Go to original source...
Go to PubMed...
- Datz C, Cramp M, Haas T, Dietze O, Nitschko H, Froesner G, et al. The natural course of hepatitis C virus infection 18 years after an epidemic outbreak of non-A, non-B hepatitis in a plasmapheresis centre. Gut. 1999 Apr;44(4):563-7.
Go to original source...
Go to PubMed...
- Muss N, Frösner GG, Sandhofer F. Epidemic outbreak of non-A, non-B hepatitis in a plasmapheresis center. I: Epidemiological observations. Infection. 1985 Mar-Apr;13(2):57-60.
Go to original source...
Go to PubMed...
- Sarrazin C, Boesecke C, Golsabahi-Broclawski S, Moog G, Negro F, Silaidos C, et al. Hepatitis C virus: current steps toward elimination in Germany and barriers to reaching the 2030 goal. Health Sci Rep. 2021 Jun 4;4(2):e290. doi: 10.1002/hsr2.290.
Go to original source...
Go to PubMed...
- Deuffic-Burban S, Huneau A, Verleene A, Brouard C, Pillonel J, Le Strat Y, et al. Assessing the cost-effectiveness of hepatitis C screening strategies in France. J Hepatol. 2018 Oct;69(4):785-92.
Go to original source...
Go to PubMed...
- Gartlehner G, Schernhammer E, Lax SF, Preusser M, Bachler H, Titzer H, et al. Screening for colorectal cancer: a recommendation statement of the Austrian National Committee for Cancer Screening. Wien Klin Wochenschr. 2023 Sep;135(17-18):447-55.
Go to original source...
Go to PubMed...
- Ola I, Cardoso R, Hoffmeister M, Brenner H. Utilization of colorectal cancer screening tests across European countries: a cross-sectional analysis of the European health interview survey 2018-2020. Lancet Reg Health Eur. 2024 Apr 29;41:100920. doi: 10.1016/j.lanepe.2024.100920.
Go to original source...
Go to PubMed...